Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program.
about
Discovery of protein acetylation patterns by deconvolution of peptide isomer mass spectra.Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program.p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis.Biology and Treatment of Rhabdoid Tumor.Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives.High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma.Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcomaThe HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
P2860
Q36341579-B1486D50-BDFE-45C2-8D61-1E0CD78D1ADDQ36489494-253E9A4E-2810-439D-B088-3F990334E8F7Q36781240-F3D3A870-C9F5-4582-B951-EB1D23B5F3F8Q38262101-792D49C4-81FD-4DCE-88DE-02449F6E242AQ38582867-08DC1C5F-7A7F-4C77-8844-D9A9312BBAAAQ39009379-B66D6779-AC41-4CBC-AC79-604C65E97AA8Q48171014-3D3594B9-9EA9-4350-BEF6-FEAC30F95AC6Q50102285-83900215-7007-4FD3-B6FE-35D9E516870DQ57243254-585E3D54-CDDD-49BF-A205-C2233A9CBC6CQ59132751-12B0945E-7C98-4C37-8D15-2DF884E5789F
P2860
Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@ast
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@nl
type
label
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@ast
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@nl
prefLabel
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@ast
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@nl
P2093
P2860
P50
P356
P1476
Initial testing (stage 1) of t ...... c Preclinical Testing Program.
@en
P2093
Amy Wozniak
Christopher L Morton
Dmitry Lyalin
Donya Moradi Manesh
E Anders Kolb
Hernan Carol
John M Maris
Peter J Houghton
Raushan T Kurmasheva
Stephen T Keir
P2860
P304
P356
10.1002/PBC.24724
P577
2013-09-04T00:00:00Z